explore -WSS

explore

author：explore 2025-09-27 18:53:50 - browse：44738

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Cancer drug shortages' outsize impact on ovarian cancer patients

explore

focus

WSS

New definition of a human embryo proposed amid rapid advances

ProMED sees offers of support, but its future remains unclear

An interview with Robert F. Kennedy Jr. on vaccines

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Chimpanzees, like humans and whales, get menopause: Study

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

focus

explore

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Trump's false claims about Georgia's 2020 election long debunked

Psychedelics group wrestles with new pharma identity

Physician subsidies by hospitals soar in wake of No Surprises Act

BioMarin wins approval for gene therapy to treat hemophilia A

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Medicare proposal to cover medical devices draws a mixed reaction

Traditional Chinese medicine benefits explored in new JAMA study

The cancer drug shortage isn’t new — and neither are the solutions

FDA has safety concerns on CRISPR

focus

Testing for cancer recurrence creates a new limbo for patients

Living with Hashimoto's and celiac disease, and med school, too

Readout Newsletter: XBI biotech index, Akero Therapeutics

Evacuations in place as 3 wildfires burn in eastern Washington state

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Beware the threat of staffing cuts at the CDC

leisure time

explore

focus

hotspot